Connect Biopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.

About CNTB

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease.

CEO

Barry D. Quart

CEOBarry D. Quart

Employees

Employees62

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2015

Founded2015

Employees

Employees62

CNTB Key Statistics

Market cap

63.10M

Market cap63.10M

Price-Earnings ratio

-4.01

Price-Earnings ratio-4.01

Dividend yield

—

Dividend yield—

Average volume

79.87K

Average volume79.87K

High today

—

High today—

Low today

—

Low today—

Open price

$1.17

Open price$1.17

Volume

0.00

Volume0.00

52 Week high

$1.60

52 Week high$1.60

52 Week low

$0.51

52 Week low$0.51

Connect Biopharma

Why Robinhood?

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. Show more

CNTB Key Statistics

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease.